Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check6 days agoChange DetectedThe page footer now shows a new revision entry (v3.3.4) replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page history shows Revision: v3.3.3 added and HHS Vulnerability Disclosure and Revision: v3.3.2 removed. These are administrative/site-structure updates that do not affect trial data or content.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.3.2 to the page history. Removed the funding lapse notice and the previous Revision: v3.2.0.SummaryDifference0.3%

- Check77 days agoChange DetectedDifference0.0%

- Check106 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference8%

- Check113 days agoChange DetectedReleased a new version: v3.1.0, replacing the old v3.0.2. This is a core content update reflecting an updated software version.SummaryDifference0.2%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.